What is Compass Laboratory Services?
Compass Laboratory Services is dedicated to advancing personalized medicine through a comprehensive suite of high-quality, industry-leading product lines. The company operates on the principle that each patient's unique risk factors, including genetic composition, lifestyle, and comorbidities, necessitate tailored treatment approaches. By providing prescription drug management testing and molecular diagnostics, Compass equips healthcare providers and patients with critical information essential for personalizing medical interventions.
How much funding has Compass Laboratory Services raised?
Compass Laboratory Services has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Compass Laboratory Services
PPP
Public-Private Partnership
What's next for Compass Laboratory Services?
The recent major strategic investment signals a pivotal growth phase for Compass Laboratory Services, likely enabling expansion of its personalized medicine offerings and molecular diagnostics capabilities. Given the large-scale late-stage funding context, the company is poised to scale its operations, enhance its technological infrastructure, and potentially broaden its market reach. This strategic capital infusion is expected to accelerate the development and deployment of its testing solutions, further solidifying its role in precision healthcare.
See full Compass Laboratory Services company page
